OOIR: Observatory of International Research

Papers

(The H4-Index of Hypertension Research is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Area of residence and hypertension risk: need more evidence from low- and middle-income countries	88
Use of calcium channel blockers does not increase breast cancer risk: findings from a nationwide population-based cohort study in Taiwan	58
Blood pressure variability in acute ischemic stroke	50
The associations of adipokines with hypertension in youth with cardiometabolic risk and the mediation role of insulin resistance: The BCAMS study	46
Preclinical diagnosis and identification of the chimeric CYP11B1/CYP11B2 gene in two pediatric cases of a Japanese family with glucocorticoid-remediable aldosteronism	43
Association between blood pressure and COVID-19 severity	43
Clarification of hypertension mechanisms provided by the research of central circulatory regulation	43
In memoriam: a tribute to Masao Ishii, MD PhD	41
Common surgical masks and unattended blood pressure changes in treated hypertensive patients	40
Differences in the effects of exercise on blood pressure depending on the physical condition of the subject and the type of exercise: a systematic review and meta-analysis	37
Predicting cognitive function and dementia risk in patients with hypertension	36
Validation of the Uscom BP+ automated oscillometric blood pressure monitor for professional office use in children and adolescents according to the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018)	35
Renal nerves and hypertension contribute to impaired proximal tubule megalin-mediated albumin uptake in renovascular hypertensive rats	35
Enhancing hypertension management: the role of corporate medical health administrators in encouraging hospital visits for workers	33
Unawareness and untreated hypertension: a public health problem needs to be solved	32
The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy	32
Cardiometabolic medicine in culture, community, and society: a unified goal with diverse approaches	31
Impact of SARS-CoV-2 variants on viral infectivity and the role of the renin-angiotensin-aldosterone system	29
Pharmacological stimulation of the parasympathetic system – a promising means of cardioprotection in heart failure	28
Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry	28
Home systolic blood pressure time in therapeutic range and cardiovascular risk: the practitioner-based nationwide J-HOP study extended	27
Cumulative muscle mass and blood pressure but not fat mass drives arterial stiffness and carotid intima-media thickness progression in the young population and is unrelated to vascular organ damage	27
Maternal angiogenic factor disruptions prior to clinical diagnosis of preeclampsia: insights from the REVAMP study	26
Original article and review highlighted in this month of Hypertension Research	26
BMA-based Mendelian randomization identifies blood metabolites as causal candidates in pregnancy-induced hypertension	26

Importance of reconfirming the validity of the revised blood pressure categories